ID   ATC1
AC   CVCL_C755
DR   Wikidata; Q54751067
RX   PubMed=11196467;
RX   PubMed=15666850;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; SV40 large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Adrenal cortex; UBERON=UBERON_0001235.
CC   Breed/subspecies: Akr1b7 promoter-T-Ag transgenic.
DI   NCIt; C22992; Mouse adrenal cortical carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   4M
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 8
//
RX   PubMed=11196467; DOI=10.3109/07435800009048613;
RA   Sahut-Barnola I., Lefrancois-Martinez A.-M., Jean C., Veyssiere G.,
RA   Martinez A.;
RT   "Adrenal tumorigenesis targeted by the corticotropin-regulated
RT   promoter of the aldo-keto reductase AKR1B7 gene in transgenic mice.";
RL   Endocr. Res. 26:885-898(2000).
//
RX   PubMed=15666850; DOI=10.1081/ERC-200044168;
RA   Ragazzon B., Lefrancois-Martinez A.-M., Val P., Tournaire C.,
RA   Berger M., Gachancard-Bouya J.-L.J., Begue R.-J., Veyssiere G.,
RA   Martinez A.;
RT   "ACTH and PRL sensitivity of highly differentiated cell lines obtained
RT   by adrenocortical targeted oncogenesis.";
RL   Endocr. Res. 30:945-950(2004).
//